Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate. Johannet P, Flint M, Chui MH, Konner J, et al. Gynecol Oncol 2025;195:173-179.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Johannet P, Flint M, Chui MH, Konner J, et al. Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate. Gynecol Oncol 2025;195:173-179.
PMID: 40121972